To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZMYM4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
363 supporting clones for gene ZMYM4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB078915 testis ZMYM4.a 1 to 432 2 to 433   tiling clone, capped   432/432
(100 %)
0 diff
(100 %id)
BX283075 adenocarcinoma, Prostate ZMYM4.a 260 to 645 1 to 386       386/386
(100 %)
1 diff
(99.8 %id)
BG499626 adenocarcinoma, Prostate ZMYM4.a 260 to 1003 1 to 735       735/741
(99 %)
10 diff
(98.7 %id)
AK308320 testis ZMYM4.a 261 to 2059 1 to 1800       1800/1800
(100 %)
1 diff
(100.0 %id)
NM_005095.2   ZMYM4.a 261 to 7253 1 to 6993 exact RefSeq, AAA   6993/6993
(100 %)
0 diff
(100 %id)
DB084125 testis ZMYM4.a 262 to 825 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
CD657628 Embryonic Stem cells ZMYM4.a 264 to 997 54 to 781       728/831
(87 %)
19 diff
(97.8 %id)
CD653525 Embryonic Stem cells ZMYM4.a 375 to 1093 9 to 726       718/821
(87 %)
15 diff
(98.2 %id)
AA251887 germinal center B cell ZMYM4.a 386 to 700 1 to 315       315/315
(100 %)
0 diff
(100 %id)
CR936741 amygdala ZMYM4.a 397 to 6762 1 to 6366   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 6366/6366
(100 %)
5 diff
(100.0 %id)
BF516492   ZMYM4.a 512 to 1124 621 to 9   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 613/621
(98 %)
0 diff
(100 %id)
BG481952 choriocarcinoma, placenta ZMYM4.a 681 to 1522 1 to 840   available from MGC,   840/1064
(78 %)
27 diff
(97.5 %id)
BC012093 Placenta, choriocarcinoma ZMYM4.a 682 to 5489 1 to 4808   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4808/4808
(100 %)
0 diff
(100 %id)
BF816897 colon_ins ZMYM4.a 1009 to 1522 555 to 39     Submitted on the opposite strand 516/556
(92 %)
10 diff
(98.3 %id)
BX647376 human fetal kidney ZMYM4.a 1031 to 7248 1 to 6219   available from DKFZ, AAA   6219/6219
(100 %)
8 diff
(99.9 %id)
AW977060   ZMYM4.a 1043 to 1620 589 to 1     Submitted on the opposite strand 589/592
(99 %)
20 diff
(96.7 %id)
BQ356247 head_neck ZMYM4.a 1044 to 1316 5 to 275       271/292
(92 %)
9 diff
(97.0 %id)
AU130015   ZMYM4.a 1072 to 1888 2 to 815   capped   814/822
(99 %)
6 diff
(99.3 %id)
CN289622 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells ZMYM4.a 1118 to 1812 12 to 706       695/706
(98 %)
7 diff
(99.1 %id)
BU508092 leiomyosarcoma, uterus ZMYM4.a 1167 to 2174 1 to 1010       1010/1124
(89 %)
19 diff
(98.4 %id)
CN289621 embryonic stem cells, cell lines H1, H7, andH9 ZMYM4.a 1245 to 1815 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
AA251795 germinal center B cell ZMYM4.a 1298 to 1621 324 to 1       324/324
(100 %)
0 diff
(100 %id)
TI_1948150692   ZMYM4.a 1306 to 2045 121 to 866       746/1175
(63 %)
16 diff
(98.7 %id)
DR432619 mixed ZMYM4.a 1308 to 2006 1 to 695       695/699
(99 %)
6 diff
(99.2 %id)
DR433226 mixed ZMYM4.a 1308 to 2010 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
DR432932 mixed ZMYM4.a 1308 to 2011 1 to 704       704/704
(100 %)
1 diff
(99.9 %id)
TI_1948150691   ZMYM4.a 1309 to 1909 125 to 727       603/1422
(42 %)
18 diff
(98.8 %id)
TI_1948150956   ZMYM4.a 1309 to 2046 125 to 871       747/1449
(51 %)
24 diff
(98.4 %id)
TI_1948150957   ZMYM4.a 1309 to 2151 123 to 972       850/1068
(79 %)
19 diff
(98.3 %id)
TI_1948151220   ZMYM4.a 1309 to 1907 125 to 724       600/1448
(41 %)
15 diff
(99.0 %id)
TI_1948151221   ZMYM4.a 1309 to 2101 120 to 919       798/1097
(72 %)
19 diff
(98.3 %id)
TI_1948151498   ZMYM4.a 1309 to 1907 126 to 723       598/1396
(42 %)
23 diff
(98.4 %id)
TI_1948151499   ZMYM4.a 1309 to 2066 122 to 883       762/1158
(65 %)
17 diff
(98.6 %id)
CV028698 mixed ZMYM4.a 1313 to 1895 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AA721223 germinal center B cell ZMYM4.a 1337 to 1460 124 to 1       124/124
(100 %)
6 diff
(95.2 %id)
DA616614   ZMYM4.a 1342 to 1932 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
CD652437 Embryonic Stem cells ZMYM4.a 1396 to 2072 7 to 682       676/748
(90 %)
18 diff
(97.6 %id)
DA330256 hippocampus ZMYM4.a 1523 to 2004 2 to 484   capped   483/483
(100 %)
4 diff
(99.2 %id)
DA246674 brain ZMYM4.a 1536 to 2123 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
BF332034 breast ZMYM4.a 1547 to 1882 350 to 3       348/350
(99 %)
3 diff
(99.2 %id)
DA383866 thalamus ZMYM4.a 1712 to 2302 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
BU192671 eye, retinoblastoma ZMYM4.a 1724 to 2566 12 to 855       844/862
(97 %)
14 diff
(98.4 %id)
DB069165 testis ZMYM4.a 1725 to 2280 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BP220931 colon ZMYM4.a 1732 to 2309 1 to 578       578/579
(99 %)
3 diff
(99.5 %id)
AL047927 uterus ZMYM4.a 1869 to 2197 1 to 328       328/328
(100 %)
2 diff
(99.4 %id)
DA771554 brain ZMYM4.a 1924 to 2495 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BQ882802 dorsal root ganglia ZMYM4.a 1942 to 2737 1 to 801       801/885
(90 %)
11 diff
(98.8 %id)
BX648067 human rectum tumor ZMYM4.a 1967 to 5495 1 to 3529   available from DKFZ,   3529/3530
(99 %)
6 diff
(99.9 %id)
DB075057 testis ZMYM4.a 1968 to 2505 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB064590 testis ZMYM4.a 1973 to 2514 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
CN289624 embryonic stem cells, DMSO-treated H9 cellline ZMYM4.a 2033 to 2477 1 to 445       445/445
(100 %)
0 diff
(100 %id)
CN289623 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells ZMYM4.a 2102 to 2752 1 to 651       651/651
(100 %)
6 diff
(99.1 %id)
BE175788 head_neck ZMYM4.a 2137 to 2600 464 to 1     Submitted on the opposite strand 464/464
(100 %)
0 diff
(100 %id)
CB161892 Liver ZMYM4.a 2148 to 2709 562 to 1     Submitted on the opposite strand 562/562
(100 %)
0 diff
(100 %id)
BF908648 uterus_tumor ZMYM4.a 2168 to 2541 13 to 386       374/386
(96 %)
9 diff
(97.7 %id)
DB095448 testis ZMYM4.a 2238 to 2794 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
BF154729 breast_normal ZMYM4.a 2265 to 2790 11 to 533       523/533
(98 %)
7 diff
(98.7 %id)
AU119575 whole embryo, mainly head ZMYM4.a 2490 to 3281 2 to 792   capped   791/792
(99 %)
6 diff
(99.3 %id)
DA744541   ZMYM4.a 2497 to 3057 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
BP313217 mammary gland ZMYM4.a 2504 to 3084 1 to 581       581/582
(99 %)
2 diff
(99.7 %id)
BP336404 coronary artery ZMYM4.a 2536 to 3118 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DB084741 testis ZMYM4.a 2545 to 3104 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB163954 thymus ZMYM4.a 2588 to 3185 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA779886 brain ZMYM4.a 2614 to 3176 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB122029 thymus ZMYM4.a 2618 to 3179 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AW505355 lymph ZMYM4.a 2643 to 3125 8 to 490       483/490
(98 %)
6 diff
(98.8 %id)
TI_154162115   ZMYM4.a 2643 to 3221 69 to 646       578/578
(100 %)
6 diff
(99.0 %id)
BF736726 bladder_tumor ZMYM4.a 2656 to 3099 1 to 443       443/443
(100 %)
1 diff
(99.8 %id)
BI055340 placenta_normal ZMYM4.a 2738 to 3096 361 to 2       360/361
(99 %)
2 diff
(99.5 %id)
BF686523 leiomyosarcoma cell line, uterus ZMYM4.a 2759 to 3522 1 to 763       763/997
(76 %)
39 diff
(96.1 %id)
BF793899 adrenal cortex carcinoma, cell line, adrenal gland ZMYM4.a 2792 to 3590 1 to 804       804/823
(97 %)
36 diff
(95.7 %id)
BQ884228 sciatic nerve ZMYM4.a 2903 to 3593 12 to 701       690/963
(71 %)
11 diff
(98.9 %id)
DB248922 uterus ZMYM4.a 2919 to 3454 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
BM837516 Ascites, stomach ZMYM4.a 2927 to 3565 1 to 639       639/639
(100 %)
3 diff
(99.6 %id)
BP383411 ilea mucosa ZMYM4.a 2936 to 3498 1 to 565       565/565
(100 %)
9 diff
(98.5 %id)
DA932396 Spleen ZMYM4.a 2959 to 3521 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA324370 hippocampus ZMYM4.a 2980 to 3522 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
CR987657 T-Lymphocytes ZMYM4.a 3029 to 3845 1 to 817       817/817
(100 %)
0 diff
(100 %id)
DA404900 thalamus ZMYM4.a 3098 to 3620 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DA542765   ZMYM4.a 3107 to 3369 8 to 270   capped   263/269
(97 %)
0 diff
(100 %id)
DB166970 kidney, tumor tissue ZMYM4.a 3107 to 3666 8 to 567   capped   560/566
(98 %)
1 diff
(99.9 %id)
DA224722 brain ZMYM4.a 3114 to 3702 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
BP280223   ZMYM4.a 3126 to 3711 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
DA802775 brain ZMYM4.a 3129 to 3697 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA725004   ZMYM4.a 3130 to 3693 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA034349   ZMYM4.a 3166 to 3699 2 to 535   capped   534/534
(100 %)
3 diff
(99.5 %id)
R14071 whole brain ZMYM4.a 3196 to 3537 1 to 351       351/365
(96 %)
17 diff
(95.4 %id)
BU193231 eye, retinoblastoma ZMYM4.a 3223 to 4033 1 to 825       825/904
(91 %)
20 diff
(97.8 %id)
DA939560 Spleen ZMYM4.a 3247 to 3821 2 to 576   capped   575/577
(99 %)
1 diff
(99.9 %id)
DA802231 brain ZMYM4.a 3330 to 3892 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
BE295009 muscle, rhabdomyosarcoma ZMYM4.a 3395 to 3982 670 to 15     Submitted on the opposite strand 590/729
(80 %)
19 diff
(97.4 %id)
T27533   ZMYM4.a 3399 to 3719 1 to 321       321/321
(100 %)
0 diff
(100 %id)
X85661   ZMYM4.a 3457 to 3689 1 to 231       233/234
(99 %)
13 diff
(94.5 %id)
DA314131 hippocampus ZMYM4.a 3498 to 4055 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB152840 thymus ZMYM4.a 3500 to 4076 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA229366 brain ZMYM4.a 3581 to 4132 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA235721 brain ZMYM4.a 3598 to 4197 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
BX490201   ZMYM4.a 3611 to 4197 1 to 587       587/590
(99 %)
3 diff
(99.5 %id)
DA045737 bladder ZMYM4.a 3619 to 4181 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
AA331947 Embryo, 8 weeks ZMYM4.a 3654 to 3860 1 to 207       207/207
(100 %)
0 diff
(100 %id)
BM857724 insulinoma, Pancreas ZMYM4.a 3698 to 4276 1 to 579       579/579
(100 %)
5 diff
(99.2 %id)
BG170855 hypernephroma, cell line, Kidney ZMYM4.a 3749 to 4498 1 to 748       748/819
(91 %)
22 diff
(97.4 %id)
BM475778 embryonal carcinoma, cell line, testis ZMYM4.a 3794 to 4692 1 to 907       906/950
(95 %)
13 diff
(98.7 %id)
DA900959   ZMYM4.a 3807 to 4408 48 to 651   capped   604/665
(90 %)
13 diff
(98.1 %id)
CB269523 adipose ZMYM4.a 3824 to 4426 1 to 603       603/604
(99 %)
1 diff
(99.9 %id)
CN289620 embryonic stem cells, DMSO-treated H9 cellline ZMYM4.a 3846 to 4286 1 to 441       441/441
(100 %)
0 diff
(100 %id)
BM541274 leiomyosarcoma, uterus ZMYM4.a 3848 to 4901 1 to 1063       1063/1087
(97 %)
34 diff
(96.9 %id)
BM798679 stomach ZMYM4.a 3893 to 4411 1 to 519       519/519
(100 %)
0 diff
(100 %id)
T27532   ZMYM4.a 3926 to 4246 1 to 321       321/321
(100 %)
1 diff
(99.7 %id)
BU569488 testis ZMYM4.a 3943 to 4579 1 to 647       647/863
(74 %)
18 diff
(98.0 %id)
BP204247 coronary artery ZMYM4.a 3968 to 4547 1 to 579       579/582
(99 %)
4 diff
(99.4 %id)
AU137992 placenta ZMYM4.a 3973 to 4706 2 to 736   capped   735/740
(99 %)
3 diff
(99.6 %id)
X85660   ZMYM4.a 3983 to 4243 256 to 1       256/256
(100 %)
13 diff
(95.0 %id)
N88270   ZMYM4.a 4008 to 4180 1 to 173       173/173
(100 %)
1 diff
(99.5 %id)
BG388628 embryonal carcinoma, cell line, testis ZMYM4.a 4021 to 4777 1 to 764       764/1024
(74 %)
24 diff
(97.7 %id)
TI_1948150959   ZMYM4.a 4034 to 4986 1079 to 128       952/1368
(69 %)
15 diff
(99.0 %id)
TI_1948150694   ZMYM4.a 4041 to 4986 1075 to 126       950/1371
(69 %)
42 diff
(97.0 %id)
BG989995 head_neck ZMYM4.a 4107 to 4266 1 to 165       165/165
(100 %)
12 diff
(92.8 %id)
AU124575   ZMYM4.a 4110 to 4919 2 to 810   capped   809/816
(99 %)
3 diff
(99.7 %id)
TI_1948151500   ZMYM4.a 4135 to 4986 978 to 125       854/1324
(64 %)
31 diff
(97.7 %id)
BE884153 leiomyosarcoma, uterus ZMYM4.a 4137 to 4779 1 to 642       642/903
(71 %)
16 diff
(98.3 %id)
CF121670 lymph ZMYM4.a 4137 to 4487 359 to 8     Submitted on the opposite strand 352/359
(98 %)
10 diff
(97.3 %id)
TI_1948150958   ZMYM4.a 4137 to 4986 974 to 124       851/1251
(68 %)
11 diff
(99.2 %id)
TI_1948151223   ZMYM4.a 4137 to 4986 986 to 129       858/1464
(58 %)
16 diff
(99.0 %id)
TI_1948151501   ZMYM4.a 4138 to 4986 991 to 130       862/1469
(58 %)
20 diff
(98.7 %id)
TI_1948151222   ZMYM4.a 4142 to 4986 980 to 126       855/1377
(62 %)
26 diff
(98.2 %id)
BE393563 endometrium, adenocarcinoma cell line, uterus ZMYM4.a 4155 to 4530 1 to 375       375/380
(98 %)
5 diff
(98.7 %id)
AL041249 testis ZMYM4.a 4165 to 4384 1 to 220       220/230
(95 %)
1 diff
(99.6 %id)
AU130475   ZMYM4.a 4209 to 5056 2 to 849   capped   848/851
(99 %)
5 diff
(99.5 %id)
DA750125   ZMYM4.a 4210 to 4794 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BP369315 testis ZMYM4.a 4242 to 4819 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BQ669068 epidermoid carcinoma, cell line, salivary gland ZMYM4.a 4276 to 5116 1 to 842       842/843
(99 %)
2 diff
(99.8 %id)
BE745541 adenocarcinoma cell line, ovary ZMYM4.a 4278 to 5066 1 to 785       785/785
(100 %)
14 diff
(98.3 %id)
BG289264 bladder, transitional cell papilloma, cell line ZMYM4.a 4307 to 5080 1 to 770       770/803
(95 %)
12 diff
(98.6 %id)
DR432616 mixed ZMYM4.a 4311 to 4986 681 to 6       676/681
(99 %)
5 diff
(99.3 %id)
DA303055 hippocampus ZMYM4.a 4313 to 4889 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BP209710 cerebellum ZMYM4.a 4326 to 4908 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BG257800 embryonal carcinoma, cell line, testis ZMYM4.a 4354 to 5123 1 to 770       770/772
(99 %)
26 diff
(96.7 %id)
DB157222 thymus ZMYM4.a 4356 to 4942 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
AA002041 liver and spleen ZMYM4.a 4359 to 4890 1 to 533   fully sequenced,   533/533
(100 %)
2 diff
(99.7 %id)
EC476871 Prostate ZMYM4.a 4369 to 4470 103 to 2       102/103
(99 %)
0 diff
(100 %id)
EC522697 Prostate ZMYM4.a 4369 to 4466 100 to 5       96/100
(96 %)
0 diff
(100 %id)
CR594772 placenta ZMYM4.a 4436 to 5495 1 to 1060       1060/1060
(100 %)
0 diff
(100 %id)
BX417432 placenta ZMYM4.a 4436 to 5416 1 to 976   AAA   976/1032
(94 %)
6 diff
(99.5 %id)
FN059313 breast carcinoma ZMYM4.a 4496 to 4575 1 to 80       80/81
(98 %)
3 diff
(96.3 %id)
BG163691 hypernephroma, cell line, Kidney ZMYM4.a 4505 to 5228 1 to 730       730/993
(73 %)
23 diff
(97.7 %id)
BM711449 eye, fetal eyes ZMYM4.a 4506 to 4972 1 to 467   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 467/467
(100 %)
0 diff
(100 %id)
DB168421 kidney, tumor tissue ZMYM4.a 4584 to 5154 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
BE271687 adenocarcinoma cell line, ovary ZMYM4.a 4627 to 5435 1 to 804       804/934
(86 %)
17 diff
(98.2 %id)
AA373428 lung ZMYM4.a 4639 to 4973 1 to 335       335/335
(100 %)
0 diff
(100 %id)
BX454428 placenta ZMYM4.a 4648 to 5486 839 to 1       839/892
(94 %)
12 diff
(98.7 %id)
TI_149307036   ZMYM4.a 4648 to 5489 925 to 86   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 838/939
(89 %)
25 diff
(97.4 %id)
AA167058   ZMYM4.a 4671 to 4917 1 to 251       251/251
(100 %)
5 diff
(98.1 %id)
AA564814 adrenal adenoma, adrenal gland ZMYM4.a 4673 to 5154 482 to 1       482/482
(100 %)
0 diff
(100 %id)
TI_149297727   ZMYM4.a 4673 to 5489 869 to 61   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 809/963
(84 %)
23 diff
(97.7 %id)
EC541259 Prostate ZMYM4.a 4682 to 4776 100 to 7       94/100
(94 %)
0 diff
(100 %id)
AA324284 brain, cerebellum ZMYM4.a 4726 to 5054 1 to 333       333/335
(99 %)
5 diff
(98.6 %id)
BM789050 Ascites, stomach ZMYM4.a 4764 to 5357 1 to 594       594/594
(100 %)
0 diff
(100 %id)
BM982743 lung, Primary Lung Cystic Fibrosis EpithelialCells ZMYM4.a 4764 to 5489 743 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 725/727
(99 %)
5 diff
(99.4 %id)
DA782082 brain ZMYM4.a 4777 to 5342 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
AL049112 testis ZMYM4.a 4796 to 5391 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
AI935191 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) ZMYM4.a 4796 to 5420 626 to 1       626/626
(100 %)
36 diff
(94.3 %id)
AI363286 brain, glioblastoma (pooled) ZMYM4.a 4814 to 5483 675 to 8       668/675
(98 %)
0 diff
(100 %id)
BE501252 pooled germ cell tumors ZMYM4.a 4814 to 5489 675 to 1       675/675
(100 %)
8 diff
(98.9 %id)
DA693833   ZMYM4.a 4814 to 5372 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
CN289625 embryonic stem cells, DMSO-treated H9 cellline ZMYM4.a 4815 to 5262 1 to 448       448/448
(100 %)
0 diff
(100 %id)
BF057048 pooled germ cell tumors ZMYM4.a 4820 to 5495 679 to 3       677/679
(99 %)
0 diff
(100 %id)
AW474958 poorly differentiated adenocarcinoma withsignet ring cell features, stomach ZMYM4.a 4844 to 5498 657 to 1       657/657
(100 %)
12 diff
(98.2 %id)
BQ019758 Chondrosarcoma, Left Pubic Bone ZMYM4.a 4853 to 5489 657 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 639/639
(100 %)
2 diff
(99.7 %id)
AA001835 liver and spleen ZMYM4.a 4860 to 5168 319 to 1   fully sequenced,   319/319
(100 %)
13 diff
(96.0 %id)
AI868802 pooled germ cell tumors ZMYM4.a 4865 to 5448 585 to 1       585/585
(100 %)
9 diff
(98.5 %id)
AI950988 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary ZMYM4.a 4865 to 5489 625 to 1       625/625
(100 %)
13 diff
(98.0 %id)
AW439246 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ZMYM4.a 4865 to 5489 626 to 1       626/626
(100 %)
5 diff
(99.3 %id)
BE771870 prostate_tumor ZMYM4.a 4880 to 5190 319 to 7       313/319
(98 %)
0 diff
(100 %id)
BU622229 Cell Line, Chondrosarcoma ZMYM4.a 4892 to 5496 616 to 12   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 605/605
(100 %)
0 diff
(100 %id)
AW593497 pooled germ cell tumors ZMYM4.a 4898 to 5489 592 to 1       592/592
(100 %)
7 diff
(98.9 %id)
AW594051 pooled germ cell tumors ZMYM4.a 4898 to 5495 600 to 3       598/600
(99 %)
0 diff
(100 %id)
BM978972 lung, Primary Lung Epithelial Cells ZMYM4.a 4904 to 5489 610 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 592/592
(100 %)
8 diff
(98.7 %id)
AI655350 pooled germ cell tumors ZMYM4.a 4907 to 5489 583 to 1       583/583
(100 %)
4 diff
(99.4 %id)
AU145883 whole embryo, mainly head ZMYM4.a 4911 to 5489 577 to 1       577/577
(100 %)
12 diff
(98.0 %id)
BF933661 nervous_tumor ZMYM4.a 4917 to 5233 323 to 7     Submitted on the opposite strand 317/323
(98 %)
0 diff
(100 %id)
AA625272 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ZMYM4.a 4930 to 5441 1 to 511       511/511
(100 %)
1 diff
(99.9 %id)
W78082 heart ZMYM4.a 4933 to 5367 1 to 437       437/437
(100 %)
2 diff
(99.6 %id)
AA521508 germinal center B cell ZMYM4.a 4942 to 5489 553 to 11   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 543/692
(78 %)
12 diff
(98.3 %id)
BM670697 eye, fetal eyes ZMYM4.a 4942 to 5489 566 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 548/548
(100 %)
0 diff
(100 %id)
AW969212   ZMYM4.a 4970 to 5488 519 to 1     Submitted on the opposite strand 519/520
(99 %)
0 diff
(100 %id)
BE349185 malignant melanoma, metastatic to lymphnode, skin ZMYM4.a 4975 to 5489 515 to 1       515/515
(100 %)
0 diff
(100 %id)
AU152068   ZMYM4.a 4975 to 5489 517 to 1       517/520
(99 %)
9 diff
(98.3 %id)
DA177286 amygdala ZMYM4.a 4976 to 5455 2 to 481   capped   480/480
(100 %)
1 diff
(99.8 %id)
DA696236   ZMYM4.a 4977 to 5551 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA632102 Kidney ZMYM4.a 4978 to 5569 2 to 594   capped   593/593
(100 %)
2 diff
(99.7 %id)
AI334349 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ZMYM4.a 5005 to 5495 491 to 1       491/491
(100 %)
0 diff
(100 %id)
BP380131 uterus ZMYM4.a 5007 to 5552 1 to 550       550/550
(100 %)
7 diff
(98.8 %id)
BP226619   ZMYM4.a 5011 to 5579 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BP205550 coronary artery ZMYM4.a 5019 to 5592 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
AI093447 uterus ZMYM4.a 5030 to 5495 467 to 2       466/467
(99 %)
0 diff
(100 %id)
AI683495 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors ZMYM4.a 5034 to 5491 459 to 1       459/459
(100 %)
2 diff
(99.6 %id)
AI221823 pooled ZMYM4.a 5035 to 5490 456 to 1       456/456
(100 %)
0 diff
(100 %id)
DA347400 substantia nigra ZMYM4.a 5040 to 5609 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA347408 substantia nigra ZMYM4.a 5040 to 5585 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
AA831678 germinal center B cell ZMYM4.a 5043 to 5489 461 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 446/446
(100 %)
1 diff
(99.8 %id)
AI632423 serous papillary carcinoma, high grade, 2pooled tumors, uterus ZMYM4.a 5057 to 5489 443 to 11   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 433/433
(100 %)
0 diff
(100 %id)
AI830624 2 pooled tumors (clear cell type), Kidney ZMYM4.a 5076 to 5497 424 to 3       422/424
(99 %)
0 diff
(100 %id)
BE858360 brain, glioblastoma (pooled) ZMYM4.a 5076 to 5490 417 to 3       415/417
(99 %)
0 diff
(100 %id)
BP268286 thyroid ZMYM4.a 5078 to 5658 1 to 582       582/582
(100 %)
12 diff
(98.0 %id)
BP267839 thyroid ZMYM4.a 5079 to 5647 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
BP370586 testis ZMYM4.a 5079 to 5498 1 to 421       421/457
(92 %)
6 diff
(98.7 %id)
AI277244 placenta ZMYM4.a 5092 to 5496 405 to 1       405/405
(100 %)
0 diff
(100 %id)
CB046604 2 pooled tumors (clear cell type), Kidney ZMYM4.a 5110 to 5489 3 to 382   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 380/382
(99 %)
6 diff
(98.5 %id)
AA604562 lung, lung tumor ZMYM4.a 5116 to 5489 373 to 1       373/373
(100 %)
1 diff
(99.8 %id)
AA897167 pooled ZMYM4.a 5130 to 5300 171 to 1       171/171
(100 %)
0 diff
(100 %id)
AA922990 pooled germ cell tumors ZMYM4.a 5130 to 5489 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
AA948458 pooled ZMYM4.a 5139 to 5497 361 to 4       358/361
(99 %)
0 diff
(100 %id)
AW242129 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ZMYM4.a 5146 to 5495 351 to 2       350/351
(99 %)
0 diff
(100 %id)
BF526589 brain, glioblastoma with EGFR amplification ZMYM4.a 5149 to 5762 1 to 608       608/609
(99 %)
16 diff
(97.4 %id)
CB046603 2 pooled tumors (clear cell type), Kidney ZMYM4.a 5154 to 5489 367 to 32   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 336/336
(100 %)
0 diff
(100 %id)
AL047928 uterus ZMYM4.a 5177 to 5497 326 to 6       321/326
(98 %)
0 diff
(100 %id)
AI018432   ZMYM4.a 5190 to 5493 303 to 1       303/303
(100 %)
1 diff
(99.7 %id)
CD300765 White Matter ZMYM4.a 5201 to 5928 1 to 748   AAA   748/945
(79 %)
24 diff
(97.5 %id)
AW196142 serous papillary carcinoma, high grade, 2pooled tumors, uterus ZMYM4.a 5215 to 5489 278 to 1       278/278
(100 %)
3 diff
(99.0 %id)
BP292604 lung ZMYM4.a 5242 to 5821 1 to 580       580/582
(99 %)
1 diff
(99.9 %id)
AU120404 whole embryo, mainly body ZMYM4.a 5250 to 6026 2 to 779   capped   778/778
(100 %)
3 diff
(99.7 %id)
BE720563 head_neck ZMYM4.a 5262 to 5541 289 to 10       280/289
(96 %)
0 diff
(100 %id)
AI264786 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ZMYM4.a 5269 to 5498 230 to 1       230/230
(100 %)
0 diff
(100 %id)
BI497266 cochlea, ear ZMYM4.a 5277 to 5489 7 to 219   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 213/219
(97 %)
6 diff
(97.3 %id)
AW235837 Kidney ZMYM4.a 5279 to 5490 213 to 1       213/213
(100 %)
7 diff
(96.8 %id)
AA902298 pooled germ cell tumors ZMYM4.a 5290 to 5444 154 to 1       154/154
(100 %)
1 diff
(99.4 %id)
BP208828 cerebellum ZMYM4.a 5293 to 5875 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BX431403 placenta ZMYM4.a 5295 to 5495 1 to 201       201/202
(99 %)
4 diff
(98.1 %id)
AU125401   ZMYM4.a 5310 to 6061 2 to 752   tiling clone, capped   751/762
(98 %)
9 diff
(98.9 %id)
BU072503 Pancreas, Purified pancreatic islet ZMYM4.a 5338 to 5419 1 to 82       82/82
(100 %)
0 diff
(100 %id)
CB158500 Liver ZMYM4.a 5409 to 5924 1 to 516       516/516
(100 %)
1 diff
(99.9 %id)
BF095983 uterus_tumor ZMYM4.a 5419 to 5940 1 to 523       523/526
(99 %)
23 diff
(95.7 %id)
BF095985 uterus_tumor ZMYM4.a 5436 to 5908 1 to 482       482/484
(99 %)
42 diff
(91.4 %id)
CK430189 eye, lacrimal gland ZMYM4.a 5503 to 5757 1 to 255       255/255
(100 %)
3 diff
(98.9 %id)
DB377522 placenta ZMYM4.a 6067 to 6643 571 to 1       571/574
(99 %)
25 diff
(95.7 %id)
AU148404   ZMYM4.a 6315 to 6762 448 to 1       448/451
(99 %)
1 diff
(99.8 %id)
BU072234 Pancreas, Purified pancreatic islet ZMYM4.a 6683 to 7249 568 to 2   tiling clone,   567/568
(99 %)
0 diff
(100 %id)
DB367679   ZMYM4.a 6693 to 7253 554 to 1       554/554
(100 %)
21 diff
(96.3 %id)
AU149067   ZMYM4.a 6704 to 7248 531 to 1       531/542
(97 %)
26 diff
(95.3 %id)
AU146476 whole embryo, mainly body ZMYM4.a 6706 to 7253 545 to 1   tiling clone,   545/547
(99 %)
12 diff
(97.9 %id)
BC127113 PCR rescued clones ZMYM4.b 1 to 5547 1 to 5547 V420I tiling clone,   5547/5547
(100 %)
1 diff
(100.0 %id)
BE908972 epithelioid carcinoma, Pancreas ZMYM4.b 5307 to 6092 1 to 789       789/818
(96 %)
20 diff
(97.6 %id)
AU127317   ZMYM4.b 5316 to 6038 2 to 729   capped   728/733
(99 %)
17 diff
(97.7 %id)
AA331631 Embryo, 8 weeks ZMYM4.b 5338 to 5541 1 to 205       205/205
(100 %)
2 diff
(99.1 %id)
BM793650 Ascites, stomach ZMYM4.b 5381 to 6033 1 to 653       653/653
(100 %)
2 diff
(99.7 %id)
BE871345 adenocarcinoma, colon ZMYM4.b 5462 to 6200 1 to 736       736/932
(78 %)
20 diff
(97.9 %id)
BG621979 placenta ZMYM4.b 5463 to 6172 1 to 712   tiling clone,   712/713
(99 %)
8 diff
(98.9 %id)
BF699086 brain, primitive neuroectoderm ZMYM4.b 5558 to 6225 1 to 659       659/866
(76 %)
16 diff
(98.2 %id)
BM504927 Pancreas, Purified pancreatic islet ZMYM4.b 5568 to 6113 1 to 546       546/546
(100 %)
2 diff
(99.7 %id)
BF241722 bone marrow, from acute myelogenous leukemia ZMYM4.b 5648 to 6298 1 to 646       646/876
(73 %)
28 diff
(96.9 %id)
BF087758 head_neck ZMYM4.b 5669 to 6166 13 to 510       498/510
(97 %)
6 diff
(98.9 %id)
AV753084 Pituitary ZMYM4.b 5671 to 6169 1 to 495       495/516
(95 %)
17 diff
(96.8 %id)
BE969781 Pancreas ZMYM4.b 5672 to 6392 1 to 728       728/782
(93 %)
29 diff
(96.3 %id)
AW015810   ZMYM4.b 5685 to 6097 1 to 413     Submitted on the opposite strand 413/413
(100 %)
3 diff
(99.3 %id)
CB120780 cervix, Uterine ZMYM4.b 5687 to 6204 1 to 517       517/517
(100 %)
3 diff
(99.5 %id)
BF432884 carcinoid, lung ZMYM4.b 5695 to 6225 1 to 531     Submitted on the opposite strand 531/531
(100 %)
4 diff
(99.3 %id)
BE504564 carcinoid, lung ZMYM4.b 5700 to 6165 1 to 466     Submitted on the opposite strand 466/466
(100 %)
0 diff
(100 %id)
BF086179 placenta_normal ZMYM4.b 5755 to 6126 1 to 372       372/373
(99 %)
12 diff
(96.8 %id)
BF368477 placenta_normal ZMYM4.b 5755 to 6126 1 to 372       372/373
(99 %)
12 diff
(96.8 %id)
BE930086 placenta_normal ZMYM4.b 5758 to 5958 29 to 229       201/229
(87 %)
6 diff
(97.4 %id)
BF086194 placenta_normal ZMYM4.b 5759 to 6126 368 to 2       367/368
(99 %)
0 diff
(100 %id)
BQ366479 placenta_normal ZMYM4.b 5759 to 5981 13 to 233       221/236
(93 %)
3 diff
(98.8 %id)
BF992216 placenta_normal ZMYM4.b 5761 to 6115 359 to 3       357/359
(99 %)
0 diff
(100 %id)
BF992222 placenta_normal ZMYM4.b 5761 to 6109 349 to 1       349/349
(100 %)
3 diff
(99.2 %id)
BQ774711 Bone, Human Chondrosarcoma Cell Line ZMYM4.b 5776 to 6514 756 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 738/738
(100 %)
3 diff
(99.6 %id)
BE930087 placenta_normal ZMYM4.b 5779 to 6107 32 to 360       329/360
(91 %)
6 diff
(98.4 %id)
BF992221 placenta_normal ZMYM4.b 5805 to 6103 311 to 14       298/311
(95 %)
0 diff
(100 %id)
AW665494 pooled ZMYM4.b 5819 to 6385 578 to 12   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 567/567
(100 %)
0 diff
(100 %id)
AI650586 pooled germ cell tumors ZMYM4.b 5850 to 6389 540 to 1       540/540
(100 %)
0 diff
(100 %id)
CB963136 Blood vessels - aorta, basilar and artery ZMYM4.b 5852 to 6279 1 to 430       430/722
(59 %)
13 diff
(98.2 %id)
AA300892 testis ZMYM4.b 5856 to 6121 1 to 266       266/266
(100 %)
1 diff
(99.7 %id)
AW959428   ZMYM4.b 5857 to 6391 1 to 550       550/564
(97 %)
47 diff
(91.7 %id)
N53984 multiple sclerosis lesions ZMYM4.b 5858 to 6330 1 to 477       477/477
(100 %)
12 diff
(97.5 %id)
AW439579 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ZMYM4.b 5873 to 6390 519 to 1       519/519
(100 %)
1 diff
(99.9 %id)
BF058229 fibrotheoma, ovary ZMYM4.b 5884 to 6383 497 to 1       497/497
(100 %)
3 diff
(99.4 %id)
AW271402 Kidney ZMYM4.b 5903 to 6389 487 to 1       487/487
(100 %)
4 diff
(99.2 %id)
AI923936 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors ZMYM4.b 5909 to 6390 482 to 1       482/482
(100 %)
0 diff
(100 %id)
BP420016 small intestine ZMYM4.b 5914 to 6396 1 to 483     Submitted on the opposite strand 483/486
(99 %)
1 diff
(99.8 %id)
AI553984 pooled ZMYM4.b 5934 to 6391 460 to 3       458/460
(99 %)
0 diff
(100 %id)
BF086178 placenta_normal ZMYM4.b 5936 to 6099 169 to 2       168/191
(87 %)
0 diff
(100 %id)
CV324846 placenta_normal ZMYM4.b 5936 to 6099 169 to 2     Submitted on the opposite strand 168/191
(87 %)
0 diff
(100 %id)
AA934906 pooled ZMYM4.b 5939 to 6390 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI341198 pooled germ cell tumors ZMYM4.b 6022 to 6389 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AW196754 pooled germ cell tumors ZMYM4.b 6022 to 6389 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AA515943 Ewing's sarcoma ZMYM4.b 6036 to 6210 1 to 175       175/175
(100 %)
7 diff
(96.0 %id)
AW627942 pooled ZMYM4.b 6038 to 6391 359 to 2       358/359
(99 %)
0 diff
(100 %id)
BE349336 malignant melanoma, metastatic to lymphnode, skin ZMYM4.b 6040 to 6506 467 to 1       467/467
(100 %)
0 diff
(100 %id)
BU753801 placenta ZMYM4.b 6046 to 6389 361 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 344/344
(100 %)
4 diff
(98.9 %id)
AA521022 germinal center B cell ZMYM4.b 6050 to 6632 593 to 14   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 580/580
(100 %)
6 diff
(99.0 %id)
AA483696 Ewing's sarcoma ZMYM4.b 6051 to 6553 1 to 503   tiling clone,   503/503
(100 %)
0 diff
(100 %id)
BE836738 prostate_normal ZMYM4.b 6052 to 6474 427 to 5       423/427
(99 %)
0 diff
(100 %id)
AA149227 uterus ZMYM4.b 6072 to 6417 1 to 349       349/432
(80 %)
8 diff
(98.2 %id)
BX100452 uterus ZMYM4.b 6073 to 6765 1 to 694       694/699
(99 %)
2 diff
(99.8 %id)
BM126296 Islets of Langerhans, Pancreas ZMYM4.b 6073 to 6197 1 to 127       127/144
(88 %)
4 diff
(97.3 %id)
BM967368 Islets of Langerhans, Pancreas ZMYM4.b 6073 to 6598 1 to 526   fully sequenced,   526/526
(100 %)
0 diff
(100 %id)
BQ129387 Islets of Langerhans, Pancreas ZMYM4.b 6073 to 6565 1 to 493   fully sequenced,   493/493
(100 %)
0 diff
(100 %id)
BE858967 Prostate ZMYM4.b 6112 to 6389 278 to 1       278/278
(100 %)
0 diff
(100 %id)
AA481668 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ZMYM4.b 6113 to 6548 1 to 436   fully sequenced,   436/436
(100 %)
0 diff
(100 %id)
R78314 placenta ZMYM4.b 6114 to 6583 1 to 482       482/485
(99 %)
15 diff
(97.0 %id)
AI079322 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ZMYM4.b 6127 to 6508 412 to 31   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 382/382
(100 %)
9 diff
(97.7 %id)
AA478921 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ZMYM4.b 6133 to 6655 1 to 523       523/523
(100 %)
0 diff
(100 %id)
AI559514 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors ZMYM4.b 6175 to 6505 355 to 25   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 331/331
(100 %)
3 diff
(99.1 %id)
TI_149292361   ZMYM4.b 6201 to 6999 871 to 80   AAA   792/921
(85 %)
11 diff
(98.9 %id)
TI_149294881   ZMYM4.b 6201 to 6999 873 to 81   AAA   793/941
(84 %)
10 diff
(99.0 %id)
CB240706 Human Lung Epithelial cells, lung ZMYM4.b 6216 to 6994 796 to 19   AAA   778/778
(100 %)
1 diff
(99.9 %id)
BM974553 lung ZMYM4.b 6236 to 6999 779 to 19   AAA   761/761
(100 %)
7 diff
(99.1 %id)
BI494521 cochlea, ear ZMYM4.b 6241 to 6501 1 to 261   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 261/261
(100 %)
5 diff
(98.1 %id)
CA314277 Human Lung Epithelial cells, lung ZMYM4.b 6243 to 6999 774 to 19   AAA   756/756
(100 %)
3 diff
(99.7 %id)
AA831360 germinal center B cell ZMYM4.b 6247 to 6632 399 to 14   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
BI494520 cochlea, ear ZMYM4.b 6286 to 6505 239 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 220/220
(100 %)
0 diff
(100 %id)
D82768   ZMYM4.b 6311 to 6510 203 to 2       202/203
(99 %)
0 diff
(100 %id)
T27345   ZMYM4.b 6311 to 6510 203 to 2     Submitted on the opposite strand 202/203
(99 %)
0 diff
(100 %id)
AI909338 breast ZMYM4.b 6312 to 6656 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AA971728 carcinoid, lung ZMYM4.b 6345 to 6695 1 to 352     Submitted on the opposite strand 352/352
(100 %)
1 diff
(99.8 %id)
BU683493 lung ZMYM4.b 6347 to 6999 671 to 19   AAA   653/653
(100 %)
0 diff
(100 %id)
AW894981 nervous_normal ZMYM4.b 6371 to 6622 261 to 11       251/282
(89 %)
0 diff
(100 %id)
BP225468   ZMYM4.b 6384 to 6966 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BU930772 Prostate ZMYM4.b 6389 to 6705 1 to 322       322/654
(49 %)
6 diff
(99.1 %id)
BE784836 large cell carcinoma, lung ZMYM4.b 6414 to 6906 1 to 478       478/479
(99 %)
24 diff
(95.0 %id)
N66733 cochlea, ear ZMYM4.b 6419 to 6995 581 to 3       579/582
(99 %)
0 diff
(100 %id)
BM504601 Pancreas, Purified pancreatic islet ZMYM4.b 6429 to 6993 565 to 1       565/565
(100 %)
0 diff
(100 %id)
BQ101158 Islets of Langerhans, Pancreas ZMYM4.b 6464 to 7000 1 to 537   tiling clone,   537/537
(100 %)
0 diff
(100 %id)
CK823143 Islets of Langerhans, Pancreas ZMYM4.b 6464 to 6999 1 to 536   AAA   536/536
(100 %)
0 diff
(100 %id)
AA478805.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ZMYM4.b 6472 to 6781 310 to 1     also hits gene NLE1 310/310
(100 %)
9 diff
(97.1 %id)
AU149938   ZMYM4.b 6498 to 6994 496 to 1       496/500
(99 %)
18 diff
(96.4 %id)
BP386254 pancreatic islet ZMYM4.b 6508 to 6987 1 to 481     Submitted on the opposite strand 481/481
(100 %)
1 diff
(99.8 %id)
BE928918 prostate_tumor ZMYM4.b 6520 to 6638 123 to 2       122/123
(99 %)
0 diff
(100 %id)
BE928908 prostate_tumor ZMYM4.b 6521 to 6625 109 to 4       106/110
(96 %)
0 diff
(100 %id)
AA977746 2 pooled tumors (clear cell type), Kidney ZMYM4.b 6533 to 6994 480 to 19   AAA   462/462
(100 %)
0 diff
(100 %id)
BQ129247 Islets of Langerhans, Pancreas ZMYM4.b 6535 to 7001 468 to 2   fully sequenced,   467/468
(99 %)
5 diff
(99.0 %id)
AA481428 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ZMYM4.b 6539 to 7000 468 to 7   fully sequenced,   462/468
(98 %)
0 diff
(100 %id)
N51853 multiple sclerosis lesions ZMYM4.b 6541 to 6994 454 to 1       454/458
(99 %)
1 diff
(99.8 %id)
AA833910 Kidney, kidney tumor ZMYM4.b 6542 to 6995 456 to 3       454/456
(99 %)
0 diff
(100 %id)
AI540205 pooled ZMYM4.b 6546 to 6995 451 to 1       451/451
(100 %)
1 diff
(99.8 %id)
AA149228 uterus ZMYM4.b 6568 to 6994 436 to 1       436/436
(100 %)
10 diff
(97.8 %id)
BM894005 Islets of Langerhans, Pancreas ZMYM4.b 6568 to 6998 435 to 5   fully sequenced,   431/435
(99 %)
5 diff
(98.9 %id)
AW276424 lung, two pooled squamous cell carcinomas ZMYM4.b 6573 to 6997 426 to 1       426/426
(100 %)
2 diff
(99.6 %id)
AI680450 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus ZMYM4.b 6599 to 6995 396 to 1       396/396
(100 %)
3 diff
(99.3 %id)
AA620460 lung, lung carcinoma ZMYM4.b 6622 to 6999 378 to 1       378/378
(100 %)
0 diff
(100 %id)
AI066701 senescent fibroblast ZMYM4.b 6630 to 7000 375 to 5       371/375
(98 %)
0 diff
(100 %id)
AI911012 pooled ZMYM4.b 6650 to 6994 361 to 17   AAA   345/345
(100 %)
2 diff
(99.5 %id)
R77943 placenta ZMYM4.b 6651 to 6970 330 to 1       330/332
(99 %)
9 diff
(97.3 %id)
BM504603 Pancreas, Purified pancreatic islet ZMYM4.b 6658 to 6993 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AI658495 Prostate ZMYM4.b 6690 to 6994 305 to 1       305/305
(100 %)
1 diff
(99.7 %id)
AI804937 Prostate ZMYM4.b 6690 to 6995 306 to 1       306/306
(100 %)
3 diff
(99.1 %id)
AI669561 Prostate ZMYM4.b 6690 to 6994 305 to 1       305/305
(100 %)
0 diff
(100 %id)
AA953350 2 pooled tumors (clear cell type), Kidney ZMYM4.b 6723 to 6994 272 to 1       272/272
(100 %)
0 diff
(100 %id)
AA127959 uterus ZMYM4.b 6751 to 6974 228 to 1       228/228
(100 %)
5 diff
(97.9 %id)
BM754689 stomach ZMYM4.b 6834 to 7193 1 to 360   tiling clone,   360/360
(100 %)
0 diff
(100 %id)
AK309705   ZMYM4.c 1 to 4459 2 to 4460 L220R S396P V629A tiling clone,   4460/4460
(100 %)
5 diff
(99.9 %id)
DA727788   ZMYM4.c 1 to 920 2 to 925   capped   924/961
(96 %)
35 diff
(96.4 %id)
DB078189 testis ZMYM4.d 1 to 311 2 to 312   tiling clone, capped   311/311
(100 %)
0 diff
(100 %id)
BC127114 PCR rescued clones ZMYM4.d 56 to 4785 1 to 4730 V128I     4730/4730
(100 %)
1 diff
(100.0 %id)
AB007885 brain ZMYM4.d 125 to 6232 1 to 6108 exact tiling clone, available from KIAA,   6108/6108
(100 %)
0 diff
(100 %id)
AL079583 testis ZMYM4.e 1 to 427 1 to 428   tiling clone, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 428/428
(100 %)
1 diff
(99.8 %id)
AL079584 testis ZMYM4.e 3564 to 3738 193 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 175/175
(100 %)
0 diff
(100 %id)
DB284354 uterus ZMYM4.f 1 to 548 2 to 550 L4X T5Y K6Q L7T K9E ... tiling clone, capped   549/549
(100 %)
1 diff
(99.9 %id)
AW470944 carcinoid, lung ZMYM4.g 1 to 488 1 to 488   tiling clone, Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
AI702860 carcinoid, lung ZMYM4.g 2 to 246 1 to 246     Submitted on the opposite strand 246/293
(83 %)
15 diff
(94.9 %id)
BE468131 carcinoid, lung ZMYM4.g 2 to 492 1 to 491 exact tiling clone, Submitted on the opposite strand 491/493
(99 %)
1 diff
(99.8 %id)
TI_154077854   ZMYM4.g 6 to 482 109 to 586     Submitted on the opposite strand 478/586
(81 %)
15 diff
(97.5 %id)
BM893913 Islets of Langerhans, Pancreas ZMYM4.h-u 1 to 379 390 to 12 D59E F60K S61N N66T S72F tiling clone,   379/390
(97 %)
0 diff
(100 %id)
DA161106 amygdala ZMYM4.i 1 to 569 2 to 568 K70D F72* tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DA100348 cerebellum ZMYM4.j-u 1 to 548 2 to 549 exact tiling clone, to resequence, capped   548/554
(98 %)
1 diff
(99.9 %id)
BI025107 marrow ZMYM4.j-u 228 to 585 1 to 357   tiling clone,   357/367
(97 %)
19 diff
(94.9 %id)
BG680392 skin, squamous cell carcinoma ZMYM4.j-u 1531 to 2320 1 to 792   tiling clone,   792/792
(100 %)
6 diff
(99.3 %id)
TI_57241479   ZMYM4.j-u 1824 to 2605 35 to 815       781/845
(92 %)
36 diff
(95.8 %id)
BI913584 brain ZMYM4.j-u 1825 to 2605 1 to 780       780/810
(96 %)
36 diff
(95.6 %id)
DA422873 cervix ZMYM4.j-u 2025 to 2586 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
CB959031 Pooled-Glandular ZMYM4.j-u 2029 to 2755 1 to 730       730/737
(99 %)
8 diff
(99.0 %id)
CD104107 Pooled-Skin ZMYM4.j-u 2049 to 2719 1 to 671       671/676
(99 %)
3 diff
(99.6 %id)
CV571722 cornea, eye ZMYM4.j-u 2194 to 2722 1 to 529   tiling clone,   529/529
(100 %)
0 diff
(100 %id)
BE773191 prostate_tumor ZMYM4.j-u 2245 to 2435 175 to 365       191/365
(52 %)
6 diff
(98.4 %id)
DB299072 cerebellum ZMYM4.j-u 2694 to 2998 306 to 1   tiling clone, to resequence,   306/306
(100 %)
1 diff
(99.7 %id)
TI_43961392   ZMYM4.k-u 1 to 796 68 to 869 exact tiling clone, to resequence,   802/917
(87 %)
29 diff
(96.9 %id)
BI489637 pooled brain, lung, testis ZMYM4.k-u 2 to 830 1 to 839 exact tiling clone,   839/849
(98 %)
34 diff
(96.0 %id)
BI490671 pooled brain, lung, testis ZMYM4.k-u 925 to 1717 835 to 1   tiling clone,   760/1074
(70 %)
77 diff
(92.9 %id)
TI_43961393   ZMYM4.k-u 925 to 1717 835 to 1   to resequence,   760/1074
(70 %)
77 diff
(92.9 %id)
CA406473 adipose ZMYM4.l-u 1 to 352 1 to 352 S35G tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 352/352
(100 %)
2 diff
(99.5 %id)
CD655452 Embryonic Stem cells ZMYM4.l-u 213 to 1042 12 to 831   tiling clone,   820/845
(97 %)
14 diff
(98.4 %id)
AI907546 breast ZMYM4.m-u 1 to 446 37 to 482 exact tiling clone,   446/492
(90 %)
2 diff
(99.6 %id)
BQ932888 sciatic nerve ZMYM4.m-u 140 to 972 1 to 835   tiling clone,   835/895
(93 %)
13 diff
(98.6 %id)
BF377919 testis_normal ZMYM4.n-u 1 to 210 7 to 214   tiling clone,   208/214
(97 %)
6 diff
(97.2 %id)
CD706384 normal nasopharynx Gene ZMYM4, variant not shown         Suspected internal deletion, this clone was ignored    
TI_1948150693   Gene ZMYM4, variant not shown         This clone was ignored    
DB138114 thymus Gene ZMYM4, variant not shown       capped This clone was ignored    
DB345167 thymus Gene ZMYM4, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j-u, .k-u, .l-u, .m-u, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI